Mutation-targeted immunotherapy for the treatment of rare cancers
Ended Project Grant Awarded Last action
- Award ID
- W81XWH2110968
- Recipient
-
William Marsh Rice University UEI K51LECU1G8N3
- Awarding agency
-
Defense Health Agency
Department of Defense
- Obligated
- $145,570
Award facts
- Assistance listing
- 12.420 Military Medical Research and Development
- Completion date
- Originally
- Place of performance
- Houston, TX 77005, USA
Award details come from USAspending.gov.
About this award
The Defense Health Agency awarded $145,570 to Rice University under the Military Medical Research and Development federal grant program (CFDA 12.420) for the period of September 30, 2021 through September 29, 2023. The project aims to develop mutation-targeted immunotherapy for the treatment of rare cancers. Through this funding, Rice University researchers will investigate medical solutions for cancer on the battlefield and for the general public. The grant supports basic, applied, and advanced biomedical research to transform healthcare for service members and Americans. The place of performance for this research is Houston, Texas.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Amendment | $0 | |
| Original award | $145,570 |
Quick answers
Who received award W81XWH2110968?
W81XWH2110968 was awarded to William Marsh Rice University by Defense Health Agency (Department of Defense) on September 30, 2021.
How much is award W81XWH2110968 worth?
$145,570 has been obligated on W81XWH2110968.
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award